Objective: Prolonged hypocalcemia but normal intact parathyroid hormone (iPTH) levels after surgery for primary hyperparathyroidism (PHPT) are referred to as 'hungry bone syndrome' (HBS). The aim was to evaluate preoperative risk factors for HBS with a focus on the impact of 25-hydroxyvitamin D (25(OH)D) deficiency. Design: Patients having undergone initial successful surgery for sporadic PHPT within 6 years were considered for retrospective analysis. Methods: A total of 385 patients were evaluated, of whom 33 (8.6%) developed HBS influencing negatively the postoperative bone metabolism. All patients underwent biochemical evaluations two days before parathyroid surgery and were followed biochemically on a daily basis in the first postoperative week and thereafter at 8 weeks and 6 months. Conclusions: No relationship was established between preoperative 25(OH)D deficiency and HBS. The only significant risk factor for HBS in multivariable analysis was high levels of preoperative iPTH. As HBS therefore cannot be predicted preoperatively, we recommend a consistent postoperative calcium and vitamin D supplementation to improve the bone metabolism.
Introduction
Primary hyperparathyroidism (PHPT) is a common endocrine disorder with an incidence of approx. 90 per 100 000 patient-years (1) . It is defined by elevation of serum calcium (Ca) due to an inappropriate elevation or unsuppressed intact parathyroid hormone (iPTH), which leads to the absorption of Ca from bone via increased osteoclastic activity and reabsorption of Ca in the renal tubules (2) . A single parathyroid tumor is the most frequent cause of PHPT, whereas multiple gland disease is less common (2) . Surgery involving adequate resection of hypersecreting tissue is the treatment of choice, resulting in an intraoperative iPTH decay of ≥50% from a defined 'baseline' level before skin incision within 10 min after excision ('Vienna Criterion') (3). iPTH reaches its lowest level on the first postoperative day with rapid subsequent recovery, while serum Ca decreases more slowly with the lowest levels between the second and third day (4, 5) .
A severe and prolonged hypocalcemia despite normal or even elevated levels of iPTH due to a rapid increase of bone formation is called 'hungry bone syndrome' (HBS) (6) . It should be treated by Ca and vitamin D supplementation (6) . The underlying reason is assumed to be the normalization of high circulating iPTH levels, followed by enhanced bone formation with increased skeletal Ca requirement. Risk factors being discussed for HBS are advanced age, higher preoperative serum Ca, iPTH, alkaline phosphatase (ALP) and osteocalcin, as well as decreased serum magnesium and albumin levels (6, 7) . Previous studies have examined the relationship between adenoma size and weight and postoperative serum Ca with conflicting results (8, 9) .
Depleted levels of 25-hydroxyvitamin D (25(OH)D), which most accurately reflect vitamin D3 insufficiency (10) , have been suggested to be a risk factor for the development of HBS: Low levels of 1,25-dihydroxyvitamin D (1,25(OH)2D), its activated endogenous variant, might be related to decreased absorption of Ca, followed by a poor mineralization of the skeleton (11) . Two studies found an association between preoperative 25(OH)D deficiency and hypocalcemia within the first postoperative week by asking the patients about the occurrence of hypocalcemic symptoms; yet, failed to measure serum Ca levels (12, 13) . In a randomized-controlled trial, Rolighed et al. found no association between 25(OH)D and postoperative serum Ca level (14) .
On the other hand, deficiency of 25(OH)D is associated with reactive hyperparathyroidism and thus elevated postoperative iPTH levels: (2, 15) 25(OH)D blunts the calcemic effect of iPTH, and while 1,25(OH)2D has an antiproliferative effect on parathyroid cells, its deficiency directly increases iPTH secretion independent of other factors.
Besides one study investigating vitamin D supplementation among PHPT patients with low 25(OH)D levels (14) , studies investigating the relationship between 25(OH)D deficiency and postoperative Ca and iPTH levels after removing a solitary parathyroid adenoma are lacking. In view of the discussion concerning perioperative vitamin D supplementation, the aim of the present study was to evaluate risk factors for HBS with a focus on the impact of preoperative 25(OH)D deficiency on peri-and postoperative Ca and iPTH levels.
Subjects and methods

Patients
For the purposes of this study, we considered patients who had undergone initial surgery for sporadic PHPT. All data were prospectively documented and retrospectively analyzed. Indication for surgery followed the guidelines of the American Association of Endocrine Surgeons (16) and the 'Guidelines for the management of asymptomatic primary hyperparathyroidism' (17) . In all patients, solitary parathyroid adenomas were removed under general anesthesia by focused parathyroidectomy, unilateral or bilateral neck exploration. The diagnosis of solitary parathyroid adenoma was predicted intraoperatively by the decline of iPTH in the serum of ≥50% below baseline ('Vienna Criterion' (3)) and postoperatively confirmed by the histological workup and long-lasting normalization of the parathyroid metabolism.
Based on the reference values of our laboratory, HBS was defined by an albumin-adjusted total serum Ca <2.20 mmol/L and an iPTH ≥15 pg/mL after postoperative day 4 (between postoperative days 5 and 7).
Patients with preoperative renal insufficiency (creatinine >1.2 mg/dL in men and >0.9 mg/dL in women; glomerular filtration rate <90 mL/min), preoperative medication possibly influencing biochemical workup (vitamin D or Ca supplementation, calcimimetic agents, bisphosphonates, thiazide diuretics and steroids), parathyroid or thyroid reintervention, hyperthyroidism, multiple gland and hereditary disease (familial hypocalciuric hypercalcemia, multiple endocrine neoplasia) were excluded.
All patients gave informed consent to all diagnostic and therapeutic procedures. The prospective data collection and the retrospective analysis were approved by the Ethics Committee of the Medical University of Vienna (resolution number 1979/2015).
Study protocol
All patients underwent biochemical evaluations two days before parathyroid surgery and intraoperatively by PTH monitoring (3) . Following the standardized study protocol, none of the patients took Ca or vitamin D supplementation three months or longer before surgery. All patients were hospitalized for one week and followed biochemically on a daily basis with a daily analysis of the study parameters in the first postoperative week and thereafter at 8 weeks and 6 months postoperatively.
Symptomatic patients (such as perioral paresthesia and tingling extremities) were supplemented after the diagnosis of an HBS (between postoperative day 5 and 7) with Ca and 25-hydroxycholecalciferol (1000 mg/880IE) in combination with 1,25-dihydroxycholecalciferol (calcitriol, 0.25 µg) twice daily. Calcitriol was given to promote absorption of dietary Ca from the gastrointestinal tract and to increase renal tubular reabsorption of Ca.
Biochemical analyses
All measurements were performed at the central laboratory of the Medical University of Vienna using standard laboratory methods. The following parameters were evaluated two days before surgery: Ca, ionized Ca (iCa), magnesium, creatinine, albumin, 25(OH)D, 1,25(OH)2D, ALP, iPTH, osteocalcin, C-terminal telopeptide of type I collagen (beta-crosslaps), procollagen type 1 amino-terminal propeptide (P1NP), bone-specific alkaline phosphatase (BAP) and testosterone. Ca excretion was measured after 24-h urine collection for Ca (24 hU Ca ). Creatinine was measured again on postoperative day one to exclude renal insufficiency due to postoperative circulatory disorders.
Ca, magnesium, creatinine, albumin and ALP were determined by a routine multianalyzer. iCa levels were measured with an ion-sensitive gas analyzer (Radiometer, Copenhagen, Denmark). Chemiluminescence immunoassays (DiaSorin, Saluggia, Italy) were used for 25(OH)D, 1,25(OH)2D and BAP. iPTH, serum markers of bone turnover (beta-crosslaps, osteocalcin P1NP) and testosterone were measured using electrochemiluminescence immunoassays (Roche Diagnostics).
Bone mineral density (BMD)
Areal bone mineral density measurements of the posteroanterior lumbar spine at L 1 -L 4 (BMD lumb ) and the left femoral neck (BMD neck ) were performed with dual-energy X-ray absorptiometry on a QDR-4500 scanner (Hologic Inc., Waltham, MA, USA). All measurements were conducted using the standard procedures recommended by the manufacturer.
Statistics
The data were prospectively documented and retrospectively analyzed. Continuous data are presented as median, 1st and 3rd quartile (interquartile range (IQR)) and categorical variables are given as absolute frequencies and percentages. Various preoperative parameters of patients with (group 1) and without (group 2) HBS are compared using either t-tests or Wilcoxon tests, depending on the distribution of the underlying continuous risk factor or chi-square tests.
Spearman correlation was used to assess the correlation structure among suspected preoperative risk factors.
Univariate, bivariate and multivariable logistic regression was used to assess the association between preoperative, potential risk factors and HBS. Right-skewed risk factors were log-transformed prior to analysis and the relative decrease in iPTH between the 'baseline' level before skin incision and the first postoperative day was grouped into three tertiles: 0-80, 80-90 and 90-100%. For a unified presentation of the results (odds ratios (OR) with 95% confidence intervals (CI)), we present ORs comparing a patient at the 33rd percentile of the respective continuous risk factor with another patient at the 66th percentile (reference).
A multivariable logistic regression model for HBS was devised based on the clinical relevance of potential risk factors and correlation among these risk factors. C-indices, which are equivalent to the area under the curve (AUC), are given to quantify the predictive performance. The c-index states the probability that a randomly chosen patient with HBS has a higher predicted risk than a randomly chosen patient without HBS, with a value of 1 representing perfect discrimination. Line diagrams with mean and one standard error of the mean visualize the progression of pre-and postoperative kinetics of Ca and iPTH. A boxplot shows the distribution of 25(OH)D two days before surgery according to the four seasons. Analysis of variance was applied to test for differences in 25(OH) D between the seasons. All available cases were used for each statistical model. Statistical significance was defined at a 2-sided level of P < 0.05. We used SAS, version 9.2 (2008; SAS Institute Inc, Cary, NC, USA) for analysis and R, version 3.2.3 for figure preparation.
Results
Study population
Overall, 385 (277 (72.0%) female and 108 (28.1%) male) patients at a median age of 59.0 (IQR: 49.0, 68.0) years were included in the present study (Fig. 1) .
By definition, HBS was documented in 33 (8.6%) subjects (group 1). Compared to group 2 (patients without HBS), group 1 was significantly older (68.0 years (IQR: 63.0, 73.0) vs 58.0 years (IQR: 49.0, 68.0); P = 0.001).
Preoperative biochemical parameters and BMD for patients in both groups are shown in Table 1 .
Focused parathyroidectomy was performed in 162 (42.1%), unilateral neck exploration in 89 (23.1%) and bilateral neck exploration in 134 (34.8%) patients. Regarding the associations between serum markers of bone turnover, osteocalcin was strongly correlated with both beta-crosslaps (r = 0.783) and P1NP (r = 0.822) and Flowchart of patients analyzed in the study period. Group 1:
patients with hungry bone syndrome (HBS); group 2: patients without HBS. The median volumes of removed adenomas, Ca and iCa were slightly associated with iPTH (r = 0.466, r = 0.420 and r = 0.554, respectively). Albumin, 24 hU Ca and testosterone were neither correlated with BMD neck (r = 0.079, r = 0.006 and r = 0.096, respectively) nor with osteocalcin (r = −0.036, r = 0.227 and r = 0.002, respectively).
Univariate, bivariate and multivariable analysis of risk factors for HBS
An analysis of 25(OH)D two days before surgery, broken down according to seasonal measurement, showed significant differences with median values of 31.6 (IQR 19.2, 49.6) nmol/L in January-March vs 51.9 (IQR 34.5, 65.8) nmol/L in July-September (P < 0.001). However, univariate analysis of 25(OH)D failed to reveal an impact on HBS (c-index = 0.587) with an OR of 0.55 (95% CI, 0.14-2.22; P = 0.388) by comparing July-September with January-March.
Univariate logistic regression of potential preoperative risk factors for HBS is shown in Table 2 . With an OR of 9.50 (95% CI 2.79-32.21; P < 0.001), a decrease of iPTH of 90-100% compared to 0-80% was significantly associated with HBS (c-index = 0.738).
Univariate logistic models adjusted for osteocalcin, BMDneck and 25(OH)D showed a significant relationship between iPTH and HBS (OR 2.09, 95% CI, 1.47-2.97; P < 0.001) ( Table 2) . iPTH had the highest predictive value (c-index = 0.785, 95% CI, 0.693-0. 
Discussion
The results of the present study document that 8.6% of the patients with sporadic PHPT developed HBS after removal of a solitary parathyroid adenoma. Irrespective of seasonal differences, 25(OH)D deficiency did not influence its occurrence. A high preoperative level of iPTH (median 256 pg/mL vs 110 pg/mL) was strongly associated with HBS, whereas there was no association between osteocalcin and BMD neck in the multivariable analysis. The incidence of HBS in this study is in accordance with the findings of Brasier et al. (10) who documented HBS in 12.6%. Other smaller case series (6, 18, 19) have found incidences between 4% and 90%. In a case report authored by Graal et al. (20) , short preoperative treatment with pamidronate and vitamin D supplementation failed to inhibit postoperative development of HBS. Preoperatively depleted levels of 25(OH)D have been variously discussed to be a risk factor for HBS (12, 13, 21, 22) . The hypothesis of HBS development is based on skeleton demineralization due to low circulating levels of 1,25(OH)2D, leading postoperatively to an increased skeletal Ca requirement (11) . However, multivariable analyses were not performed in any of the aforementioned studies and two studies were based on 'clinical symptoms' without postoperative Ca measurements (12, 13) . Another prospective investigation explored only 25(OH)D as a risk factor for HBS in patients who were treated with 1-alpha-hydroxy-vitamin D3 before surgery (21) . In the present study, 25(OH)D was not shown to be a significant risk factor for the development of HBS, neither in univariate nor in multivariable analysis. Furthermore, we did not identify an association between 25(OH)D and serum markers of bone turnover or BMD neck , which may have supported the hypothesis of an impact (2, 15) .
The present univariate analysis confirmed the risk factors for HBS discussed in literature (11, 21, 24, 25, 26) , such as high Ca, ALP and osteocalcin levels, as well as a large median volume of the hyperfunctioning parathyroid gland. However, other studies (27, 28) found no evidence for the aforementioned HBS risk factors. Likewise, the current multivariable logistic model revealed high preoperative iPTH levels as the only significant risk factor for HBS. In accordance with the study of Brasier and Nussbaum (11), patients with HBS presented preoperative iPTH levels that were increased by more than twofold.
Some of the risk factors, such as iPTH and Ca, were associated in the correlation analysis. This finding has also been documented by Nasiri et al. (29) and explained as increased Ca (re-)absorption from bone and renal tubules in case of elevated iPTH levels (2) . The studies by Zamboni and Folse (8) and Brasier and Nussbaum (11) identified the volume of the removed parathyroid gland as a predictive value. This finding may be explained by the current association between iPTH and the volume of removed adenoma. Likewise, Nasiri et al. (29) found a strong correlation between higher levels of preoperative iPTH and heavier and larger adenoma in PHPT.
Several investigations have reported radiological evidence of PHPT-related bone manifestation, such as cysts and brown tumors, bone erosions or phalanx resorption, as risk factors for HBS (19, 21, 22, 30) . In an attempt to evaluate this finding, we used preoperative BMD neck as an objective comparison parameter. BMD neck was a significant risk factor for the development of HBS in univariate, but not in the multivariable analysis. It has been argued that BMD may be an imperfect marker, as BMD changes occur slowly (7). Moreover, ostecalcin had no significant impact on the development on HBS in multivariable analysis, although osteocalcin has been reported to be a specific serum marker of bone (7) .
Testosterone is known to stimulate renal Ca transport and therefore the Ca excretion (31) . In the current univariate analysis, high levels of testosterone in males (median 5.07 pg/mL in group 1 vs 4.14 pg/mL in group 2) were a significant risk factor for HBS. On the other hand, univariate analysis revealed an inverse correlation between 24 hU Ca and HBS.
Brasier and Nussbaum (11) identified low magnesium and albumin levels in patients with HBS. Low serum magnesium is particularly found in patients with advanced bone disease in PHPT (32) . While magnesium was not associated with HBS, a decreased albumin proved to be a significant risk factor in our univariate analysis. The rationale for the latter remains unclear. A possible explanation may be the finding of Afshinnia et al. (33) , listing hypoalbuminemia as an independent risk factor for osteoporosis. Possible reasons include an activation of osteoclasts, suppression of osteogenesis and change of the metabolism of iPTH and vitamin D-binding protein (33) . However, we found no correlation between albumin and BMD neck or osteocalcin.
Postoperative HBS leads to a requirement of Ca and vitamin D supplementation (34) . According to the present analysis of risk factors, postoperative HBS cannot be predicted preoperatively. The definite diagnosis can only be made by measuring Ca and iPTH after postoperative day 4 (between postoperative day 5 and 7). Mildly symptomatic postoperative hypocalcemia due to HBS can be prevented by a postoperative supplementation of Ca and 25-hydroxycholecalciferol (1000 mg/880IE) in combination with 1,25-dihydroxycholecalciferol (calcitriol; 0.25 µg) twice a day.
We recommend a laboratory control 8 weeks postoperatively to re-evaluate the parathyroid metabolism and to reappraise the requirement of Ca and vitamin substitution.
To our knowledge, this is the largest study of its kind by analyzing 385 highly selected patients for all relevant HBS risk factors discussed in literature, along with consistent postoperative biochemical Ca and iPTH measurements. Furthermore, it is the first study to simultaneously evaluate the predictive value of preoperative 25(OH)D and different bone markers, such as osteocalcin, betacrosslaps, P1NP, BAP, BMD lumb and BMD neck . BMD of the radius is not shown in the present study. However, it was routinely measured and had a positive correlation with BMD lumb and BMD neck . 25(OH)D levels were rather high in the present study population. Nevertheless, in all patients, preoperative vitamin D supplementation in the last three months was excluded by anamnesis. As HBS occurs in approximately 10% of the patients only, multivariable analysis could only be performed for a limited number of parameters, namely iPTH, osteocalcin, BMD neck and 25(OH)D, thus yielding restricted explanatory power.
In conclusion, the present study revealed no relationships between preoperative 25(OH)D deficiency, HBS and severity of metabolic bone disease, respectively, nor with iPTH or size of parathyroid adenoma. The only significant risk factor for the development of HBS in multivariable analysis was a high level of preoperative iPTH, which was increased by more than twofold compared to patients without HBS and showed associations with Ca levels and volumes of removed adenoma. Preoperative and intraoperative parameters are unable to indicate HBS. Therefore, we suggest a consistent postoperative Ca and vitamin D supplementation as cost-effective approach to restore a 'normal' bone metabolism.
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